Delivery of systemic anti-cancer therapy during the COVID-19 pandemic
ConclusionsWith careful systematic changes, safe and continued delivery of systemic anti-cancer therapy during the COVID-19 pandemic is possible.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | COVID-19 | General Medicine | Ireland Health | Pandemics | Science